The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Serial multiomic analysis in advanced breast cancer: A novel platform to inform therapeutic decisions.
 
Ben Kong
Consulting or Advisory Role - Clarified Precision Medicine
 
Jamie Keck
No Relationships to Disclose
 
Brett Johnson
No Relationships to Disclose
 
Jayne Stommel
No Relationships to Disclose
 
Christina Zheng
Employment - Cepheid (I)
 
Kiara Siex
No Relationships to Disclose
 
Alexander Guimaraes
Honoraria - Agfa Healthcare
Consulting or Advisory Role - BioClinica; Calyx; Merck; Takeda
Expert Testimony - Witherspoon Kelly
 
Christopher L. Corless
Employment - Omics Data Automation
Stock and Other Ownership Interests - Omics Data Automation
Consulting or Advisory Role - Cepheid
Travel, Accommodations, Expenses - Cepheid
 
Zahi Ibrahim Mitri
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis (Inst); Olema Oncology (Inst); Radius Health (Inst); Seagen (Inst)
 
Joe W. Gray
Stock and Other Ownership Interests - Abbott; Abbvie; Convergent Genomics; Google; Health Technology Innovations; PDX Pharmaceutical; Procter & Gamble
Consulting or Advisory Role - Health Technology Innovations; PDX Pharmaceutical
Research Funding - Health Technology Innovations; PDX Pharmaceutical
Patents, Royalties, Other Intellectual Property - Abbott Diagnostics; New Leaf Venture; PDX Pharmaceutical
 
Gordon B. Mills
Stock and Other Ownership Interests - Bluedot; Catena; ImmunoMET; Nuvectis Pharma; SignalChem; Tarveda Therapeutics; Turbine
Honoraria - Amphista Therapeutics; Astex Pharmaceuticals; AstraZeneca; BlueDot; Chrysalis biotherapeutics; Ellipses Pharma; GlaxoSmithKline; ImmunoMET; Infinity Pharmaceuticals; Ionis Pharmaceuticals; Leapfrog Bio; Lilly; MedaCorp; NanoString Technologies; Nuvectis Pharma; PDX Pharmacy; Qureator; Roche; SignalChem; Symphogen; Tarveda Therapeutics; Turbine; Zentalis
Consulting or Advisory Role - Amphista Therapeutics; Astex Pharmaceuticals; AstraZeneca; BlueDot; Chrysalis biotherapeutics; Ellipses Pharma; GlaxoSmithKline; ImmunoMET; Infinity Pharmaceuticals; Ionis Pharmaceuticals; Leapfrog Bio; Lilly; MedaCorp; NanoString Technologies; Nuvectis Pharma; PDX Pharmacy; Qureator; Roche; SignalChem; Symphogen; Tarveda Therapeutics; Turbine; Zentalis
Research Funding - Adelson Medical Research Foundation; AstraZeneca; Breast Cancer Research Foundation; Genentech; GlaxoSmithKline; ImmunoMET; Komipharm; Lilly; NanoString Technologies; Ovarian Cancer Research Foundation; Prospect Creek Foundation
Patents, Royalties, Other Intellectual Property - DSP technology patent with Nanostring; HRD assay to Myriad Genetics
Travel, Accommodations, Expenses - AstraZeneca; Chrysalis Biomedical Advisors; ImmunoMET; Michigan Primary Care Consortium; Pfizer; Symphogen
 
Raymond C. Bergan
Research Funding - Taproot Health Inc (Inst)
Patents, Royalties, Other Intellectual Property - I hold several patents, and currently have two pending, related to small molecule therapeutics that inhibit cancer cell motility, bone destruction and screening assays for potentially active drugs.
Other Relationship - Hebei Cancer Hospital